Mediclinic and Remgro agree on terms for £3.7bn buyout
04 August 2022 - 09:20
UPDATED 04 August 2022 - 23:43
The board of SA’s most valuable hospital group, Mediclinic, has approved a revised offer from its biggest shareholder, Remgro, in a consortium with Switzerland’s MSC Mediterranean Shipping, that values its shares at £3.7bn (R74.8bn).
The buyout is one of a growing number of moves by investment holding company Remgro to reduce the discount between its share price and the underlying value of its companies. It has sold Distell to Heineken, subject to competition authority approval, and has unbundled its stake in RMI...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.